Marketwatch NCLT rejects Sun Pharma’s plan to demerge overseas subsidiary Admin January 2, 2020 The decision was approved by the Sun Pharma board in May 2018. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
